Home / Advanced Search

  • Title/Keywords

  • Author/Affliations

  • Journal

  • Article Type

  • Start Year

  • End Year

Update SearchingClear
  • Articles
  • Online
Search Results (5)
  • Open Access

    REVIEW

    Assessing the Hematological Cancer Stem Cell Landscape to Improve Immunotherapy Clinical Decisions

    Sotirios Charalampos Diamantoudis1,#,*, Androulla N. Miliotou2,#, Eleftheria Galatou2, Stergiani Telliou3, Konstantinos Sideris4, Nikolaos Grigoriadis1, Ioannis S. Vizirianakis1,2,*

    BIOCELL, Vol.49, No.10, pp. 1799-1858, 2025, DOI:10.32604/biocell.2025.067216 - 22 October 2025

    Abstract Hematological cancer stem cells (HCSCs) is a subpopulation of cells within hematological cancers that, through their characteristics, enhance malignancy and render their therapy more challenging. By uncovering the underlying mechanisms behind characteristic properties such as self-renewal, immune evasion, and conventional therapy resistance, as well as the major differences between other cancers and physiological cells, new and alternative targets can be assessed for use in existing and novel immunotherapeutic interventions. Through the evaluation of the existing literature, one can realize that there have already been several studies addressing the use of stem cell transplantation (SCT), monoclonal More > Graphic Abstract

    Assessing the Hematological Cancer Stem Cell Landscape to Improve Immunotherapy Clinical Decisions

  • Open Access

    ARTICLE

    Butyrophilin Downregulation in Chronic Lymphocytic Leukaemia: An Important Barrier to γδ T Cell-Mediated Cytotoxicity

    Natalia Lehman, Agnieszka Bojarska-Junak, Michał Zarobkiewicz*

    BIOCELL, Vol.49, No.6, pp. 1085-1099, 2025, DOI:10.32604/biocell.2025.063960 - 24 June 2025

    Abstract Introduction: Butyrophilins (BTNs) belong to the immunoglobulin superfamily; they play crucial roles in immune regulation, especially in γδ T cell activation. While their expression has been studied in solid tumours, their involvement in hematologic malignancies remains poorly understood. Objectives: We hypothesised that BTNs are dysregulated in chronic lymphocytic leukaemia (CLL), contributing to γδ T cell dysfunction and potentially influencing disease progression. Methods: In this study, we analyzed publicly available microarray and RNA-seq datasets to investigate the expression patterns of BTN genes in CLL. Results: Our findings reveal significant dysregulation of BTN gene expression in CLL, with BTN2A1, BTN3A1, BTN3A2,… More >

  • Open Access

    ARTICLE

    Automatic Leukaemia Segmentation Approach for Blood Cancer Classification Using Microscopic Images

    Anuj Sharma1, Deepak Prashar2, Arfat Ahmad Khan3, Faizan Ahmed Khan4, Settawit Poochaya3,*

    CMC-Computers, Materials & Continua, Vol.73, No.2, pp. 3629-3648, 2022, DOI:10.32604/cmc.2022.030879 - 16 June 2022

    Abstract Leukaemia is a type of blood cancer that is caused by undeveloped White Blood Cells (WBC), and it is also called a blast blood cell. In the marrow of human bones, leukaemia is developed and is responsible for blood cell generation with leukocytes and WBC, and if any cell gets blasted, then it may become a cause of death. Therefore, the diagnosis of leukaemia in its early stages helps greatly in the treatment along with saving human lives. Subsequently, in terms of detection, image segmentation techniques play a vital role, and they turn out to… More >

  • Open Access

    ARTICLE

    A prospective observational study of the effect of platelet transfusions on levels of platelet-derived cytokines, chemokines and interleukins in acute leukaemia patients with severe chemotherapy-induced cytopenia

    Torunn O. Apelseth1,2, Tor Hervig1,2, Tore Wentzel-Larsen3,4,5, Kjell Petersen6, Håkon Reikvam7, Øystein Bruserud7,8

    European Cytokine Network, Vol.22, No.1, pp. 52-62, 2011, DOI:10.1684/ecn.2011.0271

    Abstract Background. Platelet concentrates contain soluble mediators derived from both platelets and contaminating leukocytes. During platelet transfusion these mediators are transferred, and transfusion-induced modulation of the cytokine network may then occur, possibly contributing to transfusion reactions, immunomodulation, or affecting residual leukemic cells. In this prospective observational study, we investigate the effect of platelet transfusion on the systemic levels of platelet-derived cytokines, chemokines and interleukins in an unselected group of acute leukaemia patients with severe chemotherapy-induced cytopenia. Study design and methods. We investigated 31 platelet transfusions involving pre-storage, white blood cell-reduced, gamma-irradiated or pathogen-inactivated, photochemically-treated platelet concentrates… More >

  • Open Access

    ARTICLE

    Hypoxia increases HIF-1α expression and constitutive cytokine release by primary human acute myeloid leukaemia cells

    Kimberley Joanne Hatfield1, Siv Lise Bedringsaas2, Anita Ryningen3, Bjørn Tore Gjertsen1,2, Øystein Bruserud1,2

    European Cytokine Network, Vol.21, No.3, pp. 154-164, 2010, DOI:10.1684/ecn.2010.0204

    Abstract Introduction. Low oxygen tension is able to modulate the expression of several genes involved in physiological and pathological processes. A major regulator of gene expression is the heterodimeric transcrip tion factor hypoxia inducible factor-1 (HIF-1), which also regulates angiogenesis-related genes, including the protein expression of angioregulatory cytokines. Angiogenesis has been shown to play a role in haematological disorders, and low oxygen tension might thereby influence leukaemogenesis and chemosensitivity in human acute myeloid leukaemia (AML). Methods. We examined the effect of a hypoxic environment (1% O2) on in vitro-cultured, primary human AML cells with regard to HIF-1α… More >

Displaying 1-10 on page 1 of 5. Per Page